NCT07163312

Brief Summary

This study will observe patients with lower limb varicose veins who also have knee pain. Many patients with varicose veins experience swelling, heaviness, or aching in the legs, and some also report pain in or around the knee. Previous studies suggest that venous reflux and poor circulation may increase discomfort in the knee, especially when knee osteoarthritis is present. The purpose of this study is to evaluate whether treatment of varicose veins with standard endovenous procedures can improve knee pain and function. Participants will undergo standard vein treatment as part of their clinical care. We will follow them for changes in knee pain, quality of life, and leg symptoms over time. This study does not assign patients to experimental interventions. Instead, it collects information before and after treatment to better understand the relationship between varicose veins and knee pain relief. Findings from this study may help doctors identify which patients are most likely to benefit from venous treatment in terms of both leg and knee symptoms.

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
50

participants targeted

Target at P25-P50 for all trials

Timeline
6mo left

Started Oct 2025

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress55%
Oct 2025Nov 2026

First Submitted

Initial submission to the registry

August 21, 2025

Completed
19 days until next milestone

First Posted

Study publicly available on registry

September 9, 2025

Completed
22 days until next milestone

Study Start

First participant enrolled

October 1, 2025

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2026

Expected
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2026

Last Updated

September 9, 2025

Status Verified

September 1, 2025

Enrollment Period

1 year

First QC Date

August 21, 2025

Last Update Submit

September 1, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Change in Knee Pain Score (VAS)

    Visual Analog Scale (VAS, 0-10 cm)

    From baseline to 3 months after treatment

Secondary Outcomes (6)

  • Change in Knee Function and Symptoms

    Baseline, 1 month, 3 months, and 6 months

  • Change in Venous Clinical Severity Score (VCSS)

    Baseline, 1 month, 3 months, and 6 months.

  • Change in Aberdeen Varicose Vein Questionnaire (AVVQ)

    Baseline, 1 month, 3 months, and 6 months.

  • Change in Health-Related Quality of Life

    Baseline, 1 month, 3 months, and 6 months

  • Use of Analgesic Medications

    6 months.

  • +1 more secondary outcomes

Interventions

Participants will receive standard endovenous treatment for lower limb varicose veins as part of their routine clinical care. The procedure may include radiofrequency ablation (RFA), endovenous laser ablation (EVLA), or other accepted thermal ablation techniques, with or without adjunctive phlebectomy or foam sclerotherapy if clinically indicated. The intervention is performed under tumescent local anesthesia by vascular surgeons according to established guidelines. No experimental techniques or investigational devices are used.

Also known as: Endovenous Thermal Ablation (Radiofrequency Ablation or Endovenous Laser Ablation), Endovenous Treatment for Varicose Veins, Standard Varicose Vein Surgery

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

This study will include adult patients with clinically significant lower limb varicose veins (CEAP C2-C4) who also report knee pain. Participants are recruited from vascular surgery outpatient clinics and will undergo standard endovenous treatment as part of their clinical care. The study will observe changes in knee pain, function, and venous symptoms before and after treatment. Patients with advanced joint disease, systemic inflammatory disorders, or recent knee surgery are excluded to minimize confounding factors.

You may qualify if:

  • Adults aged ≥18 years. Clinical diagnosis of lower limb varicose veins with documented venous reflux on duplex ultrasound (CEAP C2-C4).
  • Presence of knee pain lasting ≥4 weeks prior to enrollment, confirmed by patient-reported VAS/NRS ≥3 at baseline.
  • Planned to undergo standard endovenous treatment (radiofrequency ablation, endovenous laser ablation, or equivalent).
  • Ability to provide informed consent and complete study questionnaires.

You may not qualify if:

  • Prior surgery or endovenous ablation for varicose veins in the same limb. History of inflammatory arthritis (e.g., rheumatoid arthritis, gout) or other systemic rheumatologic disease.
  • Recent acute knee injury (ligament, meniscus, fracture) within 6 months. Prior knee replacement or major knee surgery. Recent intra-articular injection or arthroscopy (\<3 months). Known deep vein thrombosis or history of pulmonary embolism within the past 6 months.
  • Severe peripheral arterial disease (ABI \<0.8). Pregnancy or breastfeeding. Inability to comply with follow-up schedule or complete questionnaires.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (3)

  • Lesnyak OM, Zubareva EV, Goncharova MG, Maksimov DM. [Lower extremity venous diseases in primary knee osteoarthritis]. Ter Arkh. 2017;89(5):53-59. doi: 10.17116/terarkh201789553-59. Russian.

    PMID: 28631699BACKGROUND
  • Zhang X, Joy DC. A simple specimen holder for EBIC imaging on the Hitachi S800. Microsc Res Tech. 1993 Oct 1;26(2):182-3. doi: 10.1002/jemt.1070260214. No abstract available.

    PMID: 8241555BACKGROUND
  • Reading AE, Everitt BS, Sledmere CM. The McGill Pain Questionnaire: a replication of its construction. Br J Clin Psychol. 1982 Nov;21 (Pt 4):339-49. doi: 10.1111/j.2044-8260.1982.tb00571.x.

    PMID: 7171883BACKGROUND

MeSH Terms

Conditions

Blindness, CorticalOsteoarthritis, Knee

Interventions

Radiofrequency Ablation

Condition Hierarchy (Ancestors)

BlindnessVision DisordersSensation DisordersNeurologic ManifestationsNervous System DiseasesEye DiseasesSigns and SymptomsPathological Conditions, Signs and SymptomsOsteoarthritisArthritisJoint DiseasesMusculoskeletal DiseasesRheumatic Diseases

Intervention Hierarchy (Ancestors)

Radiofrequency TherapyTherapeuticsAblation TechniquesSurgical Procedures, Operative

Central Study Contacts

Chunshui He, Doctor

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
6 Months
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Ph.D , Chief Physician of Vascular Surgery , Hospital of Chengdu University of Traditional Chinese Medicine

Study Record Dates

First Submitted

August 21, 2025

First Posted

September 9, 2025

Study Start

October 1, 2025

Primary Completion (Estimated)

October 1, 2026

Study Completion (Estimated)

November 1, 2026

Last Updated

September 9, 2025

Record last verified: 2025-09

Data Sharing

IPD Sharing
Will not share

Plan Description: Individual participant data (IPD) will not be shared because the study is observational, single-center, and involves limited sample size. Data will be used only for the purpose of this research project and protected according to institutional regulations.